Literature DB >> 21924337

Panax notoginseng saponins inhibit Zymosan A induced atherosclerosis by suppressing integrin expression, FAK activation and NF-κB translocation.

Zhongming Yuan1, Yu Liao, Gang Tian, Hua Li, Yi Jia, Haigang Zhang, Zhenghuai Tan, Xiaohui Li, Wenlong Deng, Kangdong Liu, Yiguan Zhang.   

Abstract

ETHNOPHARMACOLOGICAL SIGNIFICANCE: Panax notoginseng saponins (PNS) are ingredients extracted from traditional Chinese medicinal herb Panax notoginseng. It has been demonstrated that PNS have extensive effects on the cardiovascular system, including inhibition of platelet aggregation, increasing blood flow, improving left ventricular diastolic function in hypertensive patients and anti-inflammatory effect.
AIM OF STUDY: Recent researches indicated that PNS administration inhibited foam cells' formation. The present study was designed to study the effects of PNS on atherogenesis and to explore the relevant molecular mechanisms.
MATERIALS AND METHODS: The Zymosan A induced atherosclerosis models were used to investigate the anti-atherosclerosis effects of PNS. The integrin express array was used to check the changes of integrins. The foam cell formation was observed with transmission electron microscope. The effect of PNS on phosphorylation of FAK on threonine 397 and protein level of NF-κB was also evaluated in vitro.
RESULTS: PNS treated rats had less plaque spots on the aortas compared with Zym induced group. The formation of foam cell was inhibited by PNS. Compared with Zym treated group, the expression of most integrin families decreased except Itgav and Itgb2 after PNS treatment. PNS inhibited phosphorylation of FAK on threonine 397 and translocation of NF-κB.
CONCLUSION: High fat diet together with Zym induces atherogenesis of rat. PNS inhibits zymosan A induced atherogenesis by suppressing FAK phosphorylation, integrins expression and NF-κB translocation. Copyright Â
© 2011 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21924337     DOI: 10.1016/j.jep.2011.08.066

Source DB:  PubMed          Journal:  J Ethnopharmacol        ISSN: 0378-8741            Impact factor:   4.360


  20 in total

1.  Exploring mechanisms of Panax notoginseng saponins in treating coronary heart disease by integrating gene interaction network and functional enrichment analysis.

Authors:  Gui Yu; Jie Wang
Journal:  Chin J Integr Med       Date:  2016-05-16       Impact factor: 1.978

2.  Treating cardiovascular atherosclerotic plaques with Tongmaijiangzhi (TMJZ) capsule.

Authors:  Hong-Qiang Ren; Li Zhao; Zhong Shuang Zhang; Zhong Wang; Li Wang; Jun Cang Duan; Li Li; Zhi Hong Zhai; De Tao Qu; Hui Huang
Journal:  Afr J Tradit Complement Altern Med       Date:  2013-10-03

Review 3.  Bioactive components to inhibit foam cell formation in atherosclerosis.

Authors:  Sanjiv Singh; Senti Changkija; Rajat Mudgal; V Ravichandiran
Journal:  Mol Biol Rep       Date:  2022-01-11       Impact factor: 2.316

4.  Panax Notoginseng Saponins Ameliorates Coxsackievirus B3-Induced Myocarditis by Activating the Cystathionine-γ-Lyase/Hydrogen Sulfide Pathway.

Authors:  Lulu Pan; Yuanhai Zhang; Jiacheng Lu; Zhimin Geng; Lianhong Jia; Xing Rong; Zhenquan Wang; Qifeng Zhao; Rongzhou Wu; Maoping Chu; Chunxiang Zhang
Journal:  J Cardiovasc Transl Res       Date:  2015-11-02       Impact factor: 4.132

Review 5.  Chinese Herbal Compounds for the Prevention and Treatment of Atherosclerosis: Experimental Evidence and Mechanisms.

Authors:  Qing Liu; Jianping Li; Adam Hartstone-Rose; Jing Wang; Jiqiang Li; Joseph S Janicki; Daping Fan
Journal:  Evid Based Complement Alternat Med       Date:  2015-05-18       Impact factor: 2.629

Review 6.  Protective effects of panax notoginseng saponins on cardiovascular diseases: a comprehensive overview of experimental studies.

Authors:  Xiaochen Yang; Xingjiang Xiong; Heran Wang; Jie Wang
Journal:  Evid Based Complement Alternat Med       Date:  2014-07-24       Impact factor: 2.629

Review 7.  Panax notoginseng Saponins for Treating Coronary Artery Disease: A Functional and Mechanistic Overview.

Authors:  Lian Duan; Xingjiang Xiong; Junyuan Hu; Yongmei Liu; Jun Li; Jie Wang
Journal:  Front Pharmacol       Date:  2017-10-17       Impact factor: 5.810

8.  Sanqi panax notoginseng injection for angina pectoris.

Authors:  Xiaochen Yang; Xingjiang Xiong; Jie Wang
Journal:  Evid Based Complement Alternat Med       Date:  2014-02-16       Impact factor: 2.629

9.  Panax notoginseng Saponins Attenuate Phenotype Switching of Vascular Smooth Muscle Cells Induced by Notch3 Silencing.

Authors:  Nan Liu; Dazhi Shan; Ying Li; Hui Chen; Yonghong Gao; Yonghua Huang
Journal:  Evid Based Complement Alternat Med       Date:  2015-10-11       Impact factor: 2.629

Review 10.  Therapeutic Potential and Cellular Mechanisms of Panax Notoginseng on Prevention of Aging and Cell Senescence-Associated Diseases.

Authors:  Haiping Zhao; Ziping Han; Guangwen Li; Sijia Zhang; Yumin Luo
Journal:  Aging Dis       Date:  2017-12-01       Impact factor: 6.745

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.